In vivo imaging of endogenous pancreatic beta cell mass in healthy and type 1 diabetic subjects using [(18)F]FP-(+)-DTBZ and PET

The ability to non-invasively measure endogenous pancreatic β-cell mass (BCM) would accelerate research on the pathophysiology of diabetes and revolutionize the preclinical development of new treatments, the clinical assessment of therapeutic efficacy, and the early diagnosis and subsequent monitori...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Normandin, Marc D., Petersen, Kitt F., Ding, Yu-Shin, Lin, Shu-Fei, Naik, Sarita, Fowles, Krista, Skovronsky, Daniel M., Herold, Kevan C., McCarthy, Timothy J., Calle, Roberto A., Carson, Richard E., Treadway, Judith L., Cline, Gary W.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3737743/
https://ncbi.nlm.nih.gov/pubmed/22573821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.111.100545
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados